Clinical Journal of HIV & AIDS

 ISSN: 2689-8845

Clinical Journal of HIV & AIDS

About Journal


Clinical Journal of HIV & AIDS is an open access, peer reviewed journal that publishes novel research insights upon AIDS research that is the final stage of HIV infection, when your body can no longer fight life-threatening infections. The journal encourages novel research upon the early diagnosis and effective treatment that helps most people with HIV not go on to develop AIDS. The journal presents a series of high quality publications and a challenging forum that discusses the most recent progress in understanding the immune response to HIV, AIDS and helps build awareness in understanding how these new insights could be harnessed for prophylactic vaccines and immunotherapies.

The journal covers major article types such as original submissions, reviews, cases, case study, case series, communication, opinions, etc., covering all aspects of infection progress, immune response, as well as opportunistic infections and tumors that do not usually affect people who have working immune systems. The journal is supported by the expert guidance in the respective fields of HIV/AIDS. All the published content is permitted to use under Creative Common Attribution License.

The journal follows the Open Access mode to encourage the dissemination of the essential contributions in building up awareness and to improvise human health care.


Editorial Board



Dr. David A Reznik

Chief, Dental Services
Director
Oral Health Center, Infectious Disease Program
Grady Health System
Atlanta, GA


Prof. Peter A Clark

Professor
Department of Medical Ethics
Saint Joseph’s University
United States of America
Tel: 610-660-1465


Prof. Sylvia Lee Huang

Professor
Department of Biochemistry and Molecular Pharmacology
New York University School of Medicine
United States of America


Prof. Yuanan Lu

Professor and Director
Department of Public Health Sciences
University of Hawaii at Manoa
United States of America
Tel: 808-956-2702


Prof. Brian Wigdahl

Professor
Department of Microbiology and Immunology
Drexel University College of Medicine
United States of America
Tel: 215-991-8352


Dr. Jagdish Khubchandani

Associate Professor
Department of Physiology and Health Science
Ball State University
United States of America
Tel: 703-474-7623


Submit your manuscript to this journal through online or email us at editorialoffice@scholars.direct


Latest Articles

Research Article

Virological Suppression among HIV Infected Adolescents and Youths Receiving ART in the National Teaching and Referral Hospital in Kenya

We conducted a cross-sectional study among adolescents and youths aged 10 to 24-years in Kenyatta National Hospital who were on ART for at least six m... Read more

10.36959/695/567

Commentary

A Strategy to Defeat the Corona Virus (COVID-19) with Passive Immunotherapy (PIT)

Of the most important recently discovered disease-causing zoonotic infections of man, the primate retroviruses HIV- 1 which gave rise to AIDS and its ... Read more

10.36959/695/568

Case Study

Tenofovir Alafenamide Fumarate Induced Hypoglycemia in HIV Positive Patient with Insulin Dependent Diabetes

With the advances in highly active antiretroviral therapy, HIV is now considered a chronic disease. However, as the HIV population ages and have more ... Read more

10.36959/695/566

Research Article

Factors Associated with Time to Virological Failure among HIV Patients on First Line Antiretroviral at Kenyatta National Hospital Comprehensive Care Centre, Nairobi Kenya

Kenya has recorded a high burden of HIV with 1.5 million HIV + persons by 2015. With the adoption of 2016 ART guideline in Kenya all PLHIV now qualify... Read more

10.36959/695/565

CASE REPORT

Coadministration of Divalent Cation Mineral Supplements Causes cART Virologic Failure and HIV Mutagenesis: A Case Study

Integrase strand transfer inhibitors (INSTIs) are an important component of modern combined antiretroviral therapy (cART). The mechanism of inhibition... Read more

10.36959/695/564

Review Article

Play Sure Kits: A Form of Harm Reduction for HIV/AIDS

The HIV/AIDS epidemic in the United States is alive and well. According to the Centers for Disease Control and Prevention in 2015, 40,040 individuals ... Read more

10.36959/695/563

Review Article

Implications of Diffusion of Innovations Theory for a Culturally Sensitive Multi-sectoral Approach to HIV/AIDS Prevention

The present research uses a collective case study analysis to compare the effectiveness of HIV/AIDS public policy and culturally sensitive communicati... Read more

10.36959/695/562

RESEARCH ARTICLE

Cross Regional Differences in HIV/AIDS Prevalence in Tanzania: How Socioeconomic and Cultural Contexts Affect Perceived Individual and Group Efficacy

The purpose of this study was to conduct a cross-regional comparative analysis of the cultural, social, and economic differences that influence the HI... Read more

10.36959/695/561